Fatigue in Alzheimer's Disease: Biological Basis and Clinical Management-a Narrative Review

Overview

Journal Aging Clin Exp Res

Publisher Springer

Specialty Geriatrics

Date 2023 Jul 3

PMID 37395951

Authors

Davide Angioni

Jeremy Raffin

Pierre-Jean Ousset

Julien Delrieu

Philipe De Souto Barreto

Affiliations

Soon will be listed here.

Abstract

Background: Fatigue is a common symptom in neurodegenerative diseases and is associated with decreased cognitive performances. A full knowledge of the causes and physiopathological pathways leading to fatigue in Alzheimer's disease could help treating this symptom and obtain positive effects on cognitive functions.

Objectives: To provide an overview of the clinical conditions and the biological mechanisms leading to fatigue in Alzheimer's disease patients. To review the recent advances on fatigue management and describe the landscape of future possibilities.

Methods: We performed a narrative review including all type of studies (e.g. cross-sectional and longitudinal analysis, reviews, clinical trials).

Results: We found very few studies considering the symptom fatigue in Alzheimer's disease patients. Populations, designs, and objectives varied across studies rendering comparability across studies difficult to perform. Results from cross-sectional and longitudinal analysis suggest that the amyloid cascade may be involved in the pathogenesis of fatigue and that fatigue may be a prodromal manifestation of Alzheimer's disease. Fatigue and neurodegeneration of Alzheimer's disease could share common brain signatures (i.e. hippocampal atrophy and periventricular leukoaraiosis). Some mechanisms of aging (i.e. inflammation, mitochondrial dysfunction, telomere shortening) may be proposed to play a common underlying role in Alzheimer's disease neurodegeneration and muscle fatigability. Considering treatments, donepezil has been found to reduce cognitive fatigue in a 6-week randomized controlled study. Fatigue is frequently reported as an adverse event in patients treated by anti-amyloid agents in clinical trials.

Conclusion: The literature is actually inconclusive about the main causes of fatigue in Alzheimer's disease individuals and its potential treatments. Further research is needed to disentangle the role of several components such as comorbidities, depressive symptoms, iatrogenic factors, physical decline and neurodegeneration itself. Given the clinical relevance of this symptom, it seems to be important to systematically assess fatigue by validated tools in Alzheimer's disease clinical trials.

Citing Articles

Mapping fatigue: discovering brain regions and genes linked to fatigue susceptibility.

Zhang Y, Zhang Z, Yu Q, Jiang Y, Fei C, Wu F J Transl Med. 2025; 23(1):293.

PMID: 40055680 PMC: 11887381. DOI: 10.1186/s12967-025-06284-x.

Sex-specific clinical and neurobiological correlates of fatigue in older adults.

Toccaceli Blasi M, Alfano A, Salzillo M, Buscarnera S, Raparelli V, Cesari M Geroscience. 2024; 47(1):1151-1160.

PMID: 39129050 PMC: 11872861. DOI: 10.1007/s11357-024-01259-0.

Protocol for a construct and clinical validation study of MyCog Mobile: a remote smartphone-based cognitive screener for older adults.

Young S, McManus Dworak E, Byrne G, Jones C, Yoshino Benavente J, Yao L BMJ Open. 2024; 14(4):e083612.

PMID: 38569699 PMC: 11148704. DOI: 10.1136/bmjopen-2023-083612.

Revealing the Complexity of Fatigue: A Review of the Persistent Challenges and Promises of Artificial Intelligence.

Rudroff T Brain Sci. 2024; 14(2).

PMID: 38391760 PMC: 10886506. DOI: 10.3390/brainsci14020186.

References

Monfared A, Byrnes M, White L, Zhang Q . Alzheimer's Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022; 11(2):553-569. PMC: 9095793. DOI: 10.1007/s40120-022-00338-8. View

Lyketsos C, Carrillo M, Ryan J, Khachaturian A, Trzepacz P, Amatniek J . Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011; 7(5):532-9. PMC: 3299979. DOI: 10.1016/j.jalz.2011.05.2410. View

Fujisawa C, Umegaki H, Okamoto K, Nakashima H, Kuzuya M, Toba K . Physical Function Differences Between the Stages From Normal Cognition to Moderate Alzheimer Disease. J Am Med Dir Assoc. 2017; 18(4):368.e9-368.e15. DOI: 10.1016/j.jamda.2016.12.079. View

Alexander N, Taffet G, Horne F, Eldadah B, Ferrucci L, Nayfield S . Bedside-to-Bench conference: research agenda for idiopathic fatigue and aging. J Am Geriatr Soc. 2010; 58(5):967-75. PMC: 4540791. DOI: 10.1111/j.1532-5415.2010.02811.x. View

Zengarini E, Ruggiero C, Perez-Zepeda M, Hoogendijk E, Vellas B, Mecocci P . Fatigue: Relevance and implications in the aging population. Exp Gerontol. 2015; 70:78-83. DOI: 10.1016/j.exger.2015.07.011. View

Manjaly Z, Harrison N, Critchley H, Do C, Stefanics G, Wenderoth N . Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019; 90(6):642-651. PMC: 6581095. DOI: 10.1136/jnnp-2018-320050. View

Friedman J, Brown R, Comella C, Garber C, Krupp L, Lou J . Fatigue in Parkinson's disease: a review. Mov Disord. 2006; 22(3):297-308. DOI: 10.1002/mds.21240. View

Lin F, Chen D, Vance D, Ball K, Mapstone M . Longitudinal relationships between subjective fatigue, cognitive function, and everyday functioning in old age. Int Psychogeriatr. 2012; 25(2):275-85. PMC: 3552486. DOI: 10.1017/S1041610212001718. View

Kukla B, Anthony M, Chen S, Turnbull A, Baran T, Lin F . Brain Small-Worldness Properties and Perceived Fatigue in Mild Cognitive Impairment. J Gerontol A Biol Sci Med Sci. 2021; 77(3):541-546. PMC: 8893186. DOI: 10.1093/gerona/glab084. View

10.

Penner I, Paul F . Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017; 13(11):662-675. DOI: 10.1038/nrneurol.2017.117. View

11.

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

12.

Babulal G, Chen L, Doherty J, Murphy S, Johnson A, Roe C . Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease. J Alzheimers Dis. 2022; 87(1):141-148. PMC: 9086112. DOI: 10.3233/JAD-215708. View

13.

Shacham S . A shortened version of the Profile of Mood States. J Pers Assess. 1983; 47(3):305-6. DOI: 10.1207/s15327752jpa4703_14. View

14.

Hooper C, De Souto Barreto P, Coley N, Cesari M, Payoux P, Salabert A . Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia. Front Med (Lausanne). 2017; 4:173. PMC: 5681742. DOI: 10.3389/fmed.2017.00173. View

15.

Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

16.

Chhetri J, Ma L, Zheng Z, Liu F, Zhao J, Gu Z . Apolipoprotein E Polymorphism and Frailty: Apolipoprotein ε4 Allele Is Associated with Fatigue but Not Frailty Syndrome in a Community-Dwelling Older Population Cohort. J Nutr Health Aging. 2021; 25(4):410-415. DOI: 10.1007/s12603-020-1522-1. View

17.

Castellano J, Kim J, Stewart F, Jiang H, DeMattos R, Patterson B . Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med. 2011; 3(89):89ra57. PMC: 3192364. DOI: 10.1126/scitranslmed.3002156. View

18.

Wostyn P, De Deyn P . The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy. Med Hypotheses. 2018; 118:142-145. DOI: 10.1016/j.mehy.2018.07.007. View

19.

Buccellato F, DAnca M, Serpente M, Arighi A, Galimberti D . The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis. Biomedicines. 2022; 10(9). PMC: 9496080. DOI: 10.3390/biomedicines10092261. View

20.

Wong T, Weitzer D . Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas). 2021; 57(5). PMC: 8145228. DOI: 10.3390/medicina57050418. View